# PatientOne Outputs Update - Executive Summary & Recommendations

**Date:** December 26, 2025
**Prepared By:** Claude Code Analysis
**Subject:** Impact assessment of mcp-multiomics enhancements on PatientOne workflow

---

## Executive Summary

The mcp-multiomics server has been significantly enhanced from **5 to 9 tools**, adding critical preprocessing capabilities and upstream regulator prediction. This enhancement **DOES affect** PatientOne workflow outputs and requires regeneration of **8 output files** across all three stakeholder directories (developer, care-team, patient).

**Key Finding:** The current PatientOne outputs were generated using the OLD 5-tool workflow and do NOT include:
- ‚ùå Preprocessing pipeline (batch correction, imputation, QC)
- ‚ùå Upstream regulator predictions (kinases, TFs, drug targets)
- ‚ùå Updated tool counts (shows 36 tools, should be 40)

**Action Required:** Regenerate affected outputs using the new TEST_2_MULTIOMICS_ENHANCED.txt workflow.

---

## What Changed in mcp-multiomics?

### New Capabilities Added (4 tools)

**1. Preprocessing Pipeline (3 tools)** ‚≠ê CRITICAL for real proteomics data
- `validate_multiomics_data` - Detects batch effects and quality issues
- `preprocess_multiomics_data` - Applies ComBat batch correction, KNN imputation
- `visualize_data_quality` - Generates before/after QC plots

**Why This Matters:**
- Real proteomics data has batch effects (PC1-batch correlation 0.82)
- Without preprocessing, results reflect technical artifacts, not biology
- Batch correction is now REQUIRED step before analysis

**2. Upstream Regulator Prediction (1 tool)** ‚≠ê Identifies therapeutic targets
- `predict_upstream_regulators` - IPA-like kinase/TF/drug analysis

**Why This Matters:**
- Identifies druggable targets (PI3K, AKT1, MTOR)
- Predicts drug responses (Alpelisib, Capivasertib, Everolimus)
- Provides clinical trial recommendations

### Enhanced Capabilities (2 tools improved)
- `run_halla_analysis` - Now uses chunking strategy (1000 features/chunk = ~5 min vs days)
- `calculate_stouffer_meta` - Corrected FDR workflow (applied AFTER combination)

**Total:** 5 ‚Üí 9 tools (+4 new capabilities)

---

## What Needs to Be Updated?

### Critical Priority (Do First) üî¥

#### 1. MCP_Servers_Reference_Guide.pdf (for-developer)
**Current Issue:** Shows only 5 multiomics tools, total 36 tools
**Must Update:**
- Add 4 new tool descriptions
- Show preprocessing workflow diagram
- Update total tool count to 40
- Add upstream regulator section

**Estimated Time:** 2-3 hours
**Impact:** Critical technical documentation

#### 2. multiomics_resistance_analysis.png (for-care-team)
**Current Issue:** Missing preprocessing QC and therapeutic targets
**Must Update:**
- Add Panel A: Preprocessing QC (PCA before/after)
- Enhance Panel B: Gene results with preprocessing context
- Add Panel C: Upstream regulator predictions (kinases, drugs)
- Update Panel D: Pathway summary with therapeutic targets

**Estimated Time:** 1-2 hours
**Impact:** Clinical decision support visual

---

### High Priority (Do Second) üü°

#### 3. MCP_Report_PAT001.pdf (for-care-team)
**Current Issue:** No preprocessing details, no therapeutic targets
**Must Update:**
- Add "Data Quality & Preprocessing" section
- Add "Upstream Regulator Analysis & Therapeutic Targets" section
- Include drug recommendations (Alpelisib, Capivasertib, Everolimus)
- Add clinical trial recommendations

**Estimated Time:** 1-2 hours
**Impact:** Clinical report for oncology team

#### 4. MCP_Report_PAT001.pdf (for-developer)
**Current Issue:** Missing tool logs for 4 new tools
**Must Update:**
- Add tool execution logs for validate, preprocess, visualize, predict_upstream
- Add technical implementation notes on preprocessing
- Document batch correction parameters

**Estimated Time:** 1 hour
**Impact:** Technical documentation

---

### Medium Priority (Do Third) üü¢

#### 5. Full_Test_Prompt.pdf (for-developer)
**Current Issue:** References old TEST_2_MULTIOMICS.txt
**Must Update:**
- Replace with TEST_2_MULTIOMICS_ENHANCED.txt
- Update expected outputs section

**Estimated Time:** 30 minutes
**Impact:** Testing documentation

#### 6. medication_guide.html (for-patient)
**Current Issue:** May not include new drug recommendations
**Must Update:**
- Add Alpelisib (PI3K inhibitor) medication guide
- Add Capivasertib (AKT inhibitor) medication guide
- Add combination therapy section

**Estimated Time:** 45 minutes
**Impact:** Patient education

---

### Low Priority (Review & Update if Needed) ‚ö™

#### 7. patient_summary.html (for-patient)
**Review Needed:** Check if mentions specific treatments
**Potential Update:** Add layperson explanation of quality control

**Estimated Time:** 20 minutes
**Impact:** Patient-facing summary

#### 8. patient_infographic.png (for-patient)
**Review Needed:** Check if shows specific drug targets
**Potential Update:** Add PI3K/AKT/mTOR pathway visualization

**Estimated Time:** 30 minutes
**Impact:** Patient-facing visual

---

### Files NOT Affected ‚úÖ

- `spatial_transcriptomics_analysis.png` - Uses different server
- `histology_imaging_analysis.png` - Uses different server

---

## Recommended Action Plan

### Phase 1: Update Test Workflow (COMPLETE ‚úÖ)
- [x] Created TEST_2_MULTIOMICS_ENHANCED.txt with complete 8-step workflow
- [x] Documented expected preprocessing metrics
- [x] Documented expected upstream regulator predictions

### Phase 2: Regenerate Critical Outputs (NEXT)
**Step 1:** Run TEST_2_MULTIOMICS_ENHANCED.txt in Claude Desktop
```bash
# This will exercise all 9 tools and produce outputs including:
# - Preprocessing QC metrics (batch correction 0.82 ‚Üí 0.15)
# - Gene-level results (7 resistance genes)
# - Upstream regulators (kinases, TFs, drugs)
```

**Step 2:** Update MCP_Servers_Reference_Guide.pdf
- Use detailed specification in PATIENTONE_OUTPUTS_UPDATE_SPEC.md Section 1
- Add 4 new tool entries with full descriptions
- Update workflow diagram with preprocessing pipeline

**Step 3:** Create new multiomics_resistance_analysis.png
- Use detailed specification in PATIENTONE_OUTPUTS_UPDATE_SPEC.md Section 2
- Create 4-panel figure (QC, Results, Upstream, Pathway)

### Phase 3: Update Clinical Reports (THEN)
**Step 4:** Update MCP_Report_PAT001.pdf (care-team)
- Add preprocessing section
- Add therapeutic targets section
- Use detailed specification in PATIENTONE_OUTPUTS_UPDATE_SPEC.md Section 3

**Step 5:** Update MCP_Report_PAT001.pdf (developer)
- Add new tool logs
- Add technical notes
- Use detailed specification in PATIENTONE_OUTPUTS_UPDATE_SPEC.md Section 4

### Phase 4: Update Supporting Materials (FINALLY)
**Step 6:** Update remaining files as needed
- Full_Test_Prompt.pdf
- medication_guide.html
- patient_summary.html
- patient_infographic.png

---

## Key Validation Criteria

When regenerating outputs, verify these metrics match:

### Preprocessing Metrics ‚úÖ
- Batch effects detected: **PC1-batch r=0.82** (before correction)
- Batch correction result: **PC1-batch r=0.15** (after correction)
- Missing values imputed: **~2,000 protein + ~900 phospho**
- Outliers removed: **1 sample (Sample_07)**
- Final sample count: **14 samples (7 resistant, 7 sensitive)**

### Gene Results ‚úÖ
All 7 resistance genes should show:
- **PIK3CA:** Z=4.2, q=0.0001, Direction=UP
- **AKT1:** Z=4.5, q<0.0001, Direction=UP
- **MTOR:** Z=3.8, q=0.0003, Direction=UP
- **ABCB1:** Z=4.1, q=0.0001, Direction=UP
- **BCL2L1:** Z=3.2, q=0.002, Direction=UP
- **PTEN:** Z=-3.9, q=0.0002, Direction=DOWN
- **TP53:** Z=-2.8, q=0.005, Direction=DOWN

### Upstream Regulators ‚úÖ
- **Activated Kinases:** AKT1 (Z=3.2), MTOR (Z=2.8), PI3K (Z=3.0)
- **Inhibited TFs:** TP53 (Z=-3.5)
- **Drug Targets:** Alpelisib, Capivasertib, Everolimus
- **Clinical Trial:** NCT03602859

---

## Timeline Estimate

| Phase | Tasks | Estimated Time | Dependencies |
|-------|-------|----------------|--------------|
| **Phase 1** | Test workflow creation | ‚úÖ **COMPLETE** | None |
| **Phase 2** | Critical outputs (2 files) | 3-5 hours | Phase 1 complete |
| **Phase 3** | Clinical reports (2 files) | 2-3 hours | Phase 2 complete |
| **Phase 4** | Supporting materials (4 files) | 2-3 hours | Phase 3 complete |
| **Total** | 8 files | **7-11 hours** | Sequential |

---

## Resources Created

### 1. TEST_2_MULTIOMICS_ENHANCED.txt ‚úÖ
**Location:** `/manual_testing/PatientOne-OvarianCancer/implementation/TEST_2_MULTIOMICS_ENHANCED.txt`
**Content:** Complete 8-step workflow with all 9 tools
**Status:** Ready to use in Claude Desktop

### 2. PATIENTONE_OUTPUTS_UPDATE_SPEC.md ‚úÖ
**Location:** `/manual_testing/PatientOne-OvarianCancer/PATIENTONE_OUTPUTS_UPDATE_SPEC.md`
**Content:** Detailed specifications for each of 8 output files
**Status:** Complete technical reference

### 3. RECOMMENDATIONS_SUMMARY.md ‚úÖ
**Location:** `/manual_testing/PatientOne-OvarianCancer/RECOMMENDATIONS_SUMMARY.md`
**Content:** This document - executive summary and action plan
**Status:** Complete

---

## Questions & Decisions Needed

Before proceeding with regeneration:

1. **Scope Confirmation:**
   - Should we regenerate ALL 8 files, or prioritize critical ones only?
   - Are there deadline constraints?

2. **Review Process:**
   - Who should review clinical content (care-team outputs)?
   - Should a bioinformatician review preprocessing details?

3. **Patient Materials:**
   - How technical should patient-facing materials be?
   - Should we include clinical trial NCT numbers in patient materials?

4. **Tool Testing:**
   - Should we run TEST_2_MULTIOMICS_ENHANCED.txt now to verify outputs?
   - Do we need validation from all 9 tools before regenerating outputs?

---

## Immediate Next Steps (Recommended)

### Option A: Validate Tools First (Conservative)
1. Run TEST_2_MULTIOMICS_ENHANCED.txt in Claude Desktop
2. Verify all 9 tools execute successfully
3. Capture actual output metrics
4. Compare with expected values in specification
5. Proceed to regeneration if validation passes

### Option B: Begin Regeneration (Aggressive)
1. Start with MCP_Servers_Reference_Guide.pdf (highest priority)
2. Use specifications from PATIENTONE_OUTPUTS_UPDATE_SPEC.md
3. Validate each output as completed
4. Proceed sequentially through priority matrix

**Recommended:** **Option A** (validate first) to ensure all tools work as expected before committing to full regeneration.

---

## Success Criteria

PatientOne outputs will be considered "updated and accurate" when:

- ‚úÖ All 9 multiomics tools documented in reference guide
- ‚úÖ Total tool count shows 40 (not 36)
- ‚úÖ Preprocessing pipeline shown in all workflows
- ‚úÖ Batch correction metrics included (0.82 ‚Üí 0.15)
- ‚úÖ Upstream regulator predictions included
- ‚úÖ Drug recommendations show PI3K/AKT/mTOR inhibitors
- ‚úÖ Clinical trial NCT03602859 referenced
- ‚úÖ All validation criteria met (see above)
- ‚úÖ TEST_2_MULTIOMICS_ENHANCED.txt used as source

---

## Contact & Support

**Technical Questions:** See PATIENTONE_OUTPUTS_UPDATE_SPEC.md for detailed specifications
**Implementation Help:** All test files in `/manual_testing/PatientOne-OvarianCancer/implementation/`
**MCP Server Docs:** `/servers/mcp-multiomics/README.md` (725 lines, fully updated)

---

**Document Status:** ‚úÖ Complete and ready for user review
**Recommended Action:** Review this summary, then decide between Option A (validate first) or Option B (regenerate immediately)
**Next Step:** Await user decision on scope and approach
